CIDRAP newsletters options
Data from primary care facilities showed that antibiotic prescriptions for COVID-19 were clustered among a small proportion of clinics.
DTaP, PCV, and Hib coverage lagged behind the other childhood vaccines, as did overall coverage in some racial and income groups.
The WHO said more investigations are needed to the rise in GBS cases, though some patients tested positive for Campylobacter infection.
The study looked at deaths in both Florida and Ohio during the first 22 months of the pandemic.
The effects were equivalent to a 10-year age increase.
The source of the virus isn't clear, and genetic analysis is underway to look for clues or changes and to help with risk assessment.
The latest H5N6 case is China's fourth of the year.
Women who had HCV during pregnancy were more likely to have cesarean sections, preterm births, poor fetal growth, and fetal distress.
The CDC said the risk of the virus passing from cats to people is small but possible, and they urged owners to monitor their pets' health.
Test positivity is higher in some regions, such as the south and west, as Omicron variant proportions show ongoing shift.
The study demonstrates very low levels of resistance to Paxlovid, the antiviral drug most commonly used to treat COVID-19.
A review of 31 studies reveals that long COVID affects 16% of children and adolescents after COVID-19.
A citizen science study suggests at least 40% of antifungal-resistant Aspergillus infections in UK patients are linked to environmental exposure.
Testing was consistently conducted for only 5 of the WHO's 15 antibiotic-resistant priority pathogens.
Twelve fur farms in Finland have now been affected by H5N1 avian flu outbreaks.
This is the first study to assess COVID-related health disruptions on a patient level, the authors said.
The US is one of the countries seeing rising proportions of EG.5, a descendant of the XBB.1.9.2 Omicron subvariant.
The mutation was detected in 20% of study participants who never became sick, compared with 9% of their ill counterparts.
The results of a phase 2 trial show the experimental vaccine, when given to pregnant women, substantially reduced the risk of group B streptococcus infection in their infants.
A study found that the recombinant influenza vaccine provided better protection against hospitalization than the standard-dose vaccine.
